Risk Assessment of the Kidney Transplant Recipient
For underwriters, correctly assessing the potential mortality and morbidity risk of applicants who are past renal transplant recipients involves understanding a broad range of issues related to kidney disease, current transplantation science, long term graft success, post-transplant survival predictors, and the common causes of death in kidney transplant recipients.
Look Beyond the Medical Treatments (SCORviews)
If mortality improvement is a three-legged stool, improved treatment of disease is only one leg; the other two legs are prevention and early detection
US Life Expectancy Drops Again Amid Opioid Crisis
First time in more than 50 years that it fell twice in a row; deaths linked to synthetic opioids doubled from 2015 to 2016
SCORviews October 2017 Issue
Articles featured in the October 2017 issue of SCORviews include:
- Modeling Policyholder Behavior
- Innovations in Life Insurance
- SCOR Mortality Insight
Drug Abuse Mortality in the Insured Population
Population data show that drug-related mortality rates have more than doubled since the beginning of the century. This statistic is troubling enough as it is, but it hides the fact that almost all the increase is due to opioids, which account for just over half of the deaths.
Opioid Epidemic – How Did We Get Here?
This paper seeks to understand the unique set of circumstances that led to the dramatic rise in opioid prescriptions over the last few decades, and provide a brief overview of the resultant morbidity and mortality for the insured population.
Sepsis Mortality and Morbidity Trends – An Insurance Perspective
RGA’s Dr. Daniel Zimmerman answers questions on sepsis development and mortality trends.
Recent Trends in Mortality by Cause of Death
The Centers for Disease Control and Prevention (CDC) regularly issues news releases regarding current trends in US population mortality. In June of 2016, articles in The Washington Post and The Wall Street Journal cited new CDC data from 2015 which showed a rise in the US mortality rate.
(Article begins on page 2)
Chronic Myelogenous Leukemia: Survival has Significantly Improved
Advances in the treatment of chronic myelogenous leukemia (CML) since 2001 have resulted in greatly improved survival for this hematologic neoplasm, which earlier was treatable only with palliative measures or through a highly risky hematopoietic cell transplantation.
Obesity Trends Threaten Continued Mortality Improvements
The United States has enjoyed a trend of steadily improving age-adjusted population mortality over the past 80 years. However, two epidemics, obesity and opioid drug abuse, are threatening the extension of that trend. This issue of Housecalls addresses some aspects of the obesity epidemic.